首页>Cardiovascular drugs and therapy>Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: Results of a cost-effectiveness analysis including compliance
Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: Results of a cost-effectiveness analysis including compliance
作者单位：Aragón Health Research Institute (IIS Aragón), CIBERehd, University of Zaragoza Medical School[1]Department Gastroenterology and Hepatology, University Medical Center Utrecht, PO Box (85500[2]Division of Gastroenterology and Hepatology, Veterans Affairs Greater Los Angeles Health Care[3]Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern[4]Department of Cardiology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands[5]
换一批
